Provided by Tiger Trade Technology Pte. Ltd.

Baxter

23.97
-0.3900-1.60%
Pre-market: 23.95-0.0200-0.08%04:03 EDT
Volume:4.77M
Turnover:114.90M
Market Cap:12.39B
PE:-11.61
High:24.60
Open:24.20
Low:23.82
Close:24.36
52wk High:30.00
52wk Low:15.73
Shares:517.00M
Float Shares:514.53M
Volume Ratio:0.63
T/O Rate:0.93%
Dividend:0.04
Dividend Rate:0.17%
EPS(TTM):-2.0641
EPS(LYR):-1.8655
ROE:-14.37%
ROA:2.85%
PB:2.00
PE(LYR):-12.85

Loading ...

Baxter International Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 28

U.S. Research ROUNDUP-Blackstone, Hartford Insurance, Zevra Therapeutics

Reuters
·
Jul 27

Analysts Offer Insights on Healthcare Companies: InflaRx (IFRX) and Baxter International (BAX)

TIPRANKS
·
Jul 27

Baxter International Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 25

Earning Preview: Baxter revenue is expected to decrease by 1.06%, and institutional views are mixed-to-cautious

Earnings Agent
·
Jul 24

KTEK Aerosystems Director Baxter Increases Shareholding via On-Market Purchase

TIPRANKS
·
Jul 23

How Investors May Respond To Baxter (BAX) Class I VOLARA Recall And Quality Control Scrutiny

Simply Wall St.
·
Jul 23

Baxter International Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 23

Baxter International Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 21

Baxter International Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 18

Baxter International Inc. Stock Climbs 5.4%, Outperforms Peers

Dow Jones
·
Jul 17

Movement Alert|Baxter International Rises 5.03% in Regular Trading, Healthcare Equipment Sector Rallies Broadly

Market Focus
·
Jul 17

Baxter International is Maintained at Neutral by Goldman Sachs

Dow Jones
·
Jul 15

Baxter International Updates Segment Reporting Structure and Metrics

TIPRANKS
·
Jul 15

Baxter International Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 15

Baxter - Shared Corporate Expenses to Remain Unallocated in Segment Reporting - SEC Filing

THOMSON REUTERS
·
Jul 15

Baxter - Pharmaceuticals Segment NOW Reported Within Infusion Therapies & Platforms Division - SEC Filing

THOMSON REUTERS
·
Jul 15

Baxter - Changes Reportable Segments to Two Segments Effective Q2 2026 - SEC Filing

THOMSON REUTERS
·
Jul 15

Baxter: Changes Do not Impact Co's Previously Issued Consolidated Financial Statements Except for Its Segment Disclosures

THOMSON REUTERS
·
Jul 15

Movement Alert|Baxter International Falls 5.14% in Regular Trading, Goldman Sachs Raises Target but Maintains Neutral as Sector Sells Off

Market Focus
·
Jul 14